CompaniesCoastal Genomics

Coastal Genomics

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (18)
View all

Total Trials

18

As Lead Sponsor

17

As Collaborator

1

Total Enrollment

1,299

By Phase

PHASE2: 4PHASE1: 11PHASE1/PHASE2: 2PHASE3: 1

By Status

COMPLETED: 12UNKNOWN: 4RECRUITING: 1TERMINATED: 1
Clinical Trials Pipeline18 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
NCT00780325
NCT02737228
NCT02737462
NCT05841472
Hover over trial bars to see details

Recent Trials

NCT05841472Lead Sponsor
Anti-PD-1 Antibody Therapies of Camrelizumab in Combination With Pemetrexed and Carboplatin as First-line Treatment in Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
PHASE2Recruiting
60 participants
Started: Aug 23, 2023 · Completed: Dec 31, 2026
NCT05345912Lead Sponsor
Pharmacokinetics and Safety of 'CG-745 IV' and 'CG-750' in Healthy Male Adults
PHASE1Completed
24 participants
Started: Dec 16, 2019 · Completed: May 19, 2021
NCT05370716Lead Sponsor
"Drug-Drug Interaction Study of CG-651 in Healthy Volunteer"
PHASE1Completed
47 participants
Started: Nov 11, 2019 · Completed: May 19, 2020
NCT05393856Lead Sponsor
CG-549 Tablet Pharmacokinetics Study
PHASE1Completed
24 participants
Started: Sep 23, 2019 · Completed: Jun 30, 2020
NCT03774355Lead Sponsor
"Study to Compare Safety and Pharmacokinetics of CG1801 and CGL1802 in Healthy Volunteers"
PHASE1Completed
36 participants
Started: Dec 17, 2018 · Completed: May 3, 2019
View all 18 trials →
Related Companies
Yourgene
acquired